Advanced Intake™ demonstrates efficiency gains of up to 65% in adverse event recording and 90% accuracy and quality of data extraction
ArisGlobal , an innovative life...
Ochre Bio, a pioneer in chronic liver disease medicine development, announced a partnership with Boehringer Ingelheim focused on the discovery and development of novel,...
Veracyte, Inc., a leading cancer diagnostics company, announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance (AS)...
Profluent, the AI-first protein design company, today debuted the OpenCRISPRTM initiative, releasing the world’s first open-source, AI-generated gene editor. With this launch, Profluent demonstrates the...
AIRS Medical Inc., a leading provider of AI-powered healthcare solutions, recently announced that the company has signed supply agreements in Germany and the United...
A Significant Milestone Towards Aiding Rare Diseases Companies Leverage Cutting-Edge Technology and Consulting Expertise to Elevate Patient Care
CustomerInsights.AI is pleased to announce a global strategic...
This approval helps address an urgent unmet need, with about half of people living with early-stage NSCLC experiencing disease recurrence following surgery, despite adjuvant...
Veeva Systems announced Veeva Vault CRM Campaign Manager, a new industry-specific marketing application that simplifies and speeds non-personal promotion to healthcare professionals. Vault CRM...
ProPhase Labs, Inc., a biopharma, genomics, and diagnostics Company, announced an innovative step forward in cancer treatment research with the introduction of Project ZenQ-AI....